Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.

Liver stiffness Outcome Portal hypertension Vibration-controlled transient elastography

Journal

JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 25 07 2023
revised: 17 10 2023
accepted: 17 10 2023
medline: 9 1 2024
pubmed: 9 1 2024
entrez: 9 1 2024
Statut: epublish

Résumé

Primary biliary cholangitis (PBC) may lead to portal hypertension (PH). Spleen stiffness measurement (SSM) by vibration-controlled transient elastography accurately predicts PH. We aimed to assess SSM role in stratifying the risk of liver decompensation in PBC. In this monocentric, prospective, cross-sectional study, we included 114 patients with PBC who underwent liver stiffness measurement (LSM) and SSM. In total, 78 and 33 patients underwent two and three sequential vibration-controlled transient elastography examinations, respectively (longitudinal study). Screening for high-risk oesophageal varices by oesophagogastroduodenoscopy was performed according to guidelines and proposed to all patients with SSM >40 kPa. Among the 114 patients, 20 (17%) had LSM ≥10 kPa, whereas 17 (15%) had SSM >40 kPa. None of the patients with SSM ≤40 kPa had high-risk oesophageal varices, compared with three of 14 patients with SSM >40 kPa (21%; three refused endoscopy); any-size oesophageal varices were found in nine of 14 patients (64%). During a median follow-up of 15 months (IQR 10-31 months), five (4%) patients developed liver decompensation. The probability of liver decompensation was significantly higher among patients with both LSM ≥10 kPa and SSM >40 kPa: 41% at 24 months Both LSM and SSM predict liver decompensation in patients with PBC. SSM ≤40 kPa rules out high-risk oesophageal varices and might be used in combination with LSM to improve the prediction of PH-related complications. Spleen stiffness measurement by vibration-controlled transient elastography accurately predicts portal hypertension in patients with chronic viral hepatitis. The present study is the first to demonstrate that in primary biliary cholangitis the combination of liver stiffness and spleen stiffness measurement can significantly improve risk stratification by predicting liver decompensation. Moreover, when spleen stiffness is combined with liver stiffness measurement and platelet count, it aids in identifying individuals with a low probability of having high-risk oesophageal varices, thereby allowing the avoidance of unnecessary endoscopy examinations. Further validation of our results in larger cohorts of patients with primary biliary cholangitis is needed to implement spleen stiffness measurement in clinical practice.

Sections du résumé

Background & Aims UNASSIGNED
Primary biliary cholangitis (PBC) may lead to portal hypertension (PH). Spleen stiffness measurement (SSM) by vibration-controlled transient elastography accurately predicts PH. We aimed to assess SSM role in stratifying the risk of liver decompensation in PBC.
Methods UNASSIGNED
In this monocentric, prospective, cross-sectional study, we included 114 patients with PBC who underwent liver stiffness measurement (LSM) and SSM. In total, 78 and 33 patients underwent two and three sequential vibration-controlled transient elastography examinations, respectively (longitudinal study). Screening for high-risk oesophageal varices by oesophagogastroduodenoscopy was performed according to guidelines and proposed to all patients with SSM >40 kPa.
Results UNASSIGNED
Among the 114 patients, 20 (17%) had LSM ≥10 kPa, whereas 17 (15%) had SSM >40 kPa. None of the patients with SSM ≤40 kPa had high-risk oesophageal varices, compared with three of 14 patients with SSM >40 kPa (21%; three refused endoscopy); any-size oesophageal varices were found in nine of 14 patients (64%). During a median follow-up of 15 months (IQR 10-31 months), five (4%) patients developed liver decompensation. The probability of liver decompensation was significantly higher among patients with both LSM ≥10 kPa and SSM >40 kPa: 41% at 24 months
Conclusions UNASSIGNED
Both LSM and SSM predict liver decompensation in patients with PBC. SSM ≤40 kPa rules out high-risk oesophageal varices and might be used in combination with LSM to improve the prediction of PH-related complications.
Impact and implications UNASSIGNED
Spleen stiffness measurement by vibration-controlled transient elastography accurately predicts portal hypertension in patients with chronic viral hepatitis. The present study is the first to demonstrate that in primary biliary cholangitis the combination of liver stiffness and spleen stiffness measurement can significantly improve risk stratification by predicting liver decompensation. Moreover, when spleen stiffness is combined with liver stiffness measurement and platelet count, it aids in identifying individuals with a low probability of having high-risk oesophageal varices, thereby allowing the avoidance of unnecessary endoscopy examinations. Further validation of our results in larger cohorts of patients with primary biliary cholangitis is needed to implement spleen stiffness measurement in clinical practice.

Identifiants

pubmed: 38192539
doi: 10.1016/j.jhepr.2023.100952
pii: S2589-5559(23)00283-5
pmc: PMC10772386
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100952

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

All the authors declare no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Auteurs

Cristina Rigamonti (C)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Micol Giulia Cittone (MG)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Giulia Francesca Manfredi (GF)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Carla De Benedittis (C)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Noemi Paggi (N)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Francesca Baorda (F)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Davide Di Benedetto (D)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Rosalba Minisini (R)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Mario Pirisi (M)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Classifications MeSH